A prospective randomized controlled trial assessing the efficacy of adjunctive hyperbaric oxygen therapy in the treatment of hidradenitis suppurativa

Author:

Yildiz Hamza1,Senol Levent2,Ercan Erdinc3,Bilgili Memet Ersan4,Karabudak Abuaf Ozlem5

Affiliation:

1. Department of Dermatology; Eskisehir Military Hospital; Eskisehir Turkey

2. Turkish Air Force Aeromedical Research and Training Center; Eskisehir Turkey

3. Department of Hyperbaric Medicine; Eskisehir Military Hospital; Eskisehir Turkey

4. Department of Dermatology; Yunus Emre State Hospital; Eskisehir Turkey

5. Department of Dermatology; Gata Haydarpasa Teaching Hospital; Istanbul Turkey

Publisher

Wiley

Subject

Dermatology

Reference16 articles.

1. Hidradenitis suppurativa: a comprehensive review;Alikhan;J Am Acad Dermatol,2009

2. A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa;Lee;J Am Acad Dermatol,2009

3. Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial;Grant;J Am Acad Dermatol,2010

4. Hidradenitis suppurativa: a practical review of possible medical treatments based on over 350 hidradenitis patients;Scheinfeld;Dermatol Online J,2013

5. Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients;Gener;Dermatology,2009

Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3